Pfizer (PFE) Shareholder Hallmark Capital Management Has Raised Position; Seatown Holdings Lifted Thermo Fisher Scientific (TMO) Stake by $10.63 Million

Pfizer Inc. (NYSE:PFE) Logo

Seatown Holdings increased its stake in Thermo Fisher Scientific Inc (TMO) by 74.05% based on its latest 2018Q4 regulatory filing with the SEC. Seatown Holdings bought 47,649 shares as the company’s stock rose 4.87% with the market. The institutional investor held 112,000 shares of the industrial machinery and components company at the end of 2018Q4, valued at $25.06 million, up from 64,351 at the end of the previous reported quarter. Seatown Holdings who had been investing in Thermo Fisher Scientific Inc for a number of months, seems to be bullish on the $104.97 billion market cap company. The stock increased 0.63% or $1.66 during the last trading session, reaching $263.09. About 2.37M shares traded or 29.74% up from the average. Thermo Fisher Scientific Inc. (NYSE:TMO) has risen 26.43% since March 17, 2018 and is uptrending. It has outperformed by 22.06% the S&P500. Some Historical TMO News: 01/05/2018 – Spectrum Pharmaceuticals Enters into a Next-Generation Sequencing Companion Diagnostic Partnership with Thermo Fisher; 15/03/2018 – Charit√© — Universit√§tsmedizin Berlin Joins Thermo Fisher Scientific’s Next-Generation Sequencing Center of Excellence; 01/05/2018 – S&PGR Upgrades Thermo Fisher Scientific To ‘BBB+’; Otlk Stable; 16/03/2018 – Thermo Fisher Statement on IntegenX Purchase Doesn’t Include Deal Price; 25/04/2018 – Thermo Fisher 1Q Rev $5.85B; 12/04/2018 – Thermo Fisher Presenting at Conference Apr 15; 25/04/2018 – Thermo Fisher Had Seen 2018 Revenue $23.42B-$23.72B; 16/04/2018 – Thermo Fisher Presenting at Conference Tomorrow; 16/05/2018 – Thermo Fisher Scientific Installs First Glacios Cryo-Electron Microscope for Drug Discovery and Development; 25/04/2018 – Thermo Fisher 1Q Organic Revenue Growth 7%

Hallmark Capital Management Inc increased its stake in Pfizer Inc (PFE) by 45.93% based on its latest 2018Q4 regulatory filing with the SEC. Hallmark Capital Management Inc bought 98,436 shares as the company’s stock declined 4.08% while stock markets rallied. The institutional investor held 312,767 shares of the health care company at the end of 2018Q4, valued at $13.65M, up from 214,331 at the end of the previous reported quarter. Hallmark Capital Management Inc who had been investing in Pfizer Inc for a number of months, seems to be bullish on the $231.95B market cap company. The stock increased 1.43% or $0.59 during the last trading session, reaching $41.78. About 70.94 million shares traded or 160.80% up from the average. Pfizer Inc. (NYSE:PFE) has risen 20.88% since March 17, 2018 and is uptrending. It has outperformed by 16.51% the S&P500. Some Historical PFE News: 08/05/2018 – XTALPI REPORTS STRATEGIC RESEARCH PACT WITH PFIZER TO DEVELOP; 09/04/2018 – CANADA OKS TECENTRIQ FOR METASTATIC NON-SMALL CELL LUNG CANCER; 04/04/2018 – Riding a wave of positive PhIII readouts, Pfizer gets a snap review for lung cancer drug dacomitinib $PFE; 23/03/2018 – GSK pulls out of $20 bln race for Pfizer assets; 30/05/2018 – Pfizer’s Xeljanz Gets Expanded FDA Approval for Adults With Moderately to Severely Active Ulcerative Colitis; 30/05/2018 – FDA:XELJANZ HAS BOXED WARNING FOR SERIOUS INFECTIONS,MALIGNANCY; 21/03/2018 – RECKITT BENCKISER SAYS ENDED TALKS W/ PFIZER ON CONSUMER HEALTH; 26/04/2018 – PFIZER INC – SHAREHOLDERS SUPPORTED BOARD-SPONSORED PROPOSALS TO APPROVE, ON AN ADVISORY BASIS, COMPENSATION OF CO’S NAMED EXECUTIVE OFFICERS; 10/04/2018 – PFIZER – INDEPENDENT COMMITTEE FOR PHASE 3 ATLAS TRIAL OF INLYTA RECOMMENDED STOPPING TRIAL AT A PLANNED INTERIM ANALYSIS DUE TO FUTILITY; 27/03/2018 – Global Human Growth Hormone (hGH) Market Analysis & Outlook 2018-2022 with Profiles of Novartis, Pfizer, Eli Lilly and Co and Novo Nordisk – ResearchAndMarkets.com

Since January 30, 2019, it had 0 buys, and 1 insider sale for $1.81 million activity.

Investors sentiment decreased to 0.74 in 2018 Q4. Its down 0.11, from 0.85 in 2018Q3. It is negative, as 42 investors sold PFE shares while 792 reduced holdings. 141 funds opened positions while 477 raised stakes. 4.05 billion shares or 2.27% more from 3.96 billion shares in 2018Q3 were reported. 444 were reported by Lloyds Banking Gp Plc. Wells Fargo Mn holds 39.92M shares. Economic Planning Gru Adv holds 20,393 shares. Merian Invsts (Uk) Limited holds 67,211 shares or 0.03% of its portfolio. The California-based National Bank & Trust Of The West has invested 0.93% in Pfizer Inc. (NYSE:PFE). Georgia-based Chatham Capital Gp Inc has invested 0.38% in Pfizer Inc. (NYSE:PFE). Carlton Hofferkamp And Jenks Wealth Mgmt Lc holds 1.88% or 60,254 shares. Palisades Hudson Asset Mgmt LP reported 0.44% in Pfizer Inc. (NYSE:PFE). Ckw Fincl Grp Incorporated holds 0% or 380 shares. Lbmc Invest Advsr Ltd Company owns 7,923 shares for 0.06% of their portfolio. Lee Danner And Bass holds 165,807 shares or 0.85% of its portfolio. Puzo Michael J has 0.32% invested in Pfizer Inc. (NYSE:PFE). Hm Payson And Com holds 2.4% of its portfolio in Pfizer Inc. (NYSE:PFE) for 18,757 shares. Utah Retirement invested in 1.08M shares or 1.07% of the stock. Saturna holds 1.20M shares or 1.76% of its portfolio.

Hallmark Capital Management Inc, which manages about $816.74M and $765.25M US Long portfolio, decreased its stake in Wells Fargo & Co (NYSE:WFC) by 9,767 shares to 279,437 shares, valued at $12.88 million in 2018Q4, according to the filing. It also reduced its holding in Anthem Inc (NYSE:ANTM) by 3,363 shares in the quarter, leaving it with 71,654 shares, and cut its stake in Ross Stores Inc (NASDAQ:ROST).

More notable recent Pfizer Inc. (NYSE:PFE) news were published by: Seekingalpha.com which released: “Pfizer prices $5B debt offering – Seeking Alpha” on March 05, 2019, also Fool.com with their article: “What Pharma Investors Need to Know About Pfizer’s Latest Disaster – Motley Fool” published on February 21, 2019, Seekingalpha.com published: “Study links Pfizer’s Celebrex to heart valve problems – Seeking Alpha” on February 25, 2019. More interesting news about Pfizer Inc. (NYSE:PFE) were released by: Seekingalpha.com and their article: “Pfizer Inc. (PFE) Management Presents at Cowen and Company 39th Annual Health Care Conference (Transcript) – Seeking Alpha” published on March 12, 2019 as well as Investorplace.com‘s news article titled: “The Case Against Pfizer Stock and the Rest of the Industry – Investorplace.com” with publication date: March 15, 2019.

Seatown Holdings, which manages about $230.33 million US Long portfolio, decreased its stake in Ishares Tr (EEM) by 750,000 shares to 756,151 shares, valued at $29.54M in 2018Q4, according to the filing. It also reduced its holding in Mastercard Incorporated (NYSE:MA) by 81,556 shares in the quarter, leaving it with 5,744 shares, and cut its stake in Facebook Inc (NASDAQ:FB).

Investors sentiment increased to 0.89 in Q4 2018. Its up 0.04, from 0.85 in 2018Q3. It increased, as 38 investors sold TMO shares while 451 reduced holdings. 123 funds opened positions while 313 raised stakes. 354.55 million shares or 6.33% more from 333.46 million shares in 2018Q3 were reported. 30,000 are owned by Rhenman And Asset. Moreover, Dorsey And Whitney has 0.15% invested in Thermo Fisher Scientific Inc. (NYSE:TMO) for 3,876 shares. Signature & Limited Liability Corporation reported 97,003 shares. Willow Creek Wealth Mgmt Inc owns 0.71% invested in Thermo Fisher Scientific Inc. (NYSE:TMO) for 5,942 shares. Choate Investment reported 0.04% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO). Blackrock Incorporated owns 26.18 million shares for 0.3% of their portfolio. 77,341 were reported by Lodestar Invest Counsel Il. Alpha Windward Ltd reported 1,425 shares. 3,810 were reported by Cypress Asset Tx. Paloma Ptnrs Mgmt accumulated 0.05% or 6,673 shares. 4,500 were accumulated by Cullen Capital Management Limited Liability Co. Putnam Fl Invest Management holds 0.71% or 29,001 shares in its portfolio. Webster Commercial Bank N A holds 1.08% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO) for 29,938 shares. Covington Advsrs Incorporated owns 14,496 shares. Oppenheimer And holds 87,325 shares or 0.61% of its portfolio.

More news for Thermo Fisher Scientific Inc. (NYSE:TMO) were recently published by: Seekingalpha.com, which released: “Expanded use for Thermo Fisher CDx test OK’d in Japan – Seeking Alpha” on February 26, 2019. Seekingalpha.com‘s article titled: “Thermo Fisher files for mixed shelf offering – Seeking Alpha” and published on February 28, 2019 is yet another important article.

Since October 1, 2018, it had 0 buys, and 5 selling transactions for $39.04 million activity. $4.26 million worth of Thermo Fisher Scientific Inc. (NYSE:TMO) was sold by Herrema Gregory J. on Thursday, November 29. CASPER MARC N also sold $31.07 million worth of Thermo Fisher Scientific Inc. (NYSE:TMO) shares. $2.29 million worth of Thermo Fisher Scientific Inc. (NYSE:TMO) was sold by Williamson Stephen on Friday, December 7.

Thermo Fisher Scientific Inc. (NYSE:TMO) Institutional Positions Chart